Driving Diversification and Reach in Clinical Trials

This document is a guide that discusses the challenges and solutions related to inclusivity and diversity in clinical trials. It outlines the importance of diversity in clinical trials for the development of safe and effective medications. The guide emphasizes that regulatory bodies like the FDA now require diversity in clinical studies, highlighting the risks associated with insufficiently diverse trial populations. It presents community-based decentralized clinical trial (DCT) solutions as a means to enhance participant recruitment and retention by bringing trials closer to diverse patient communities. The document details how technology, particularly mobile devices, can facilitate access to clinical trials, improve data collection, and engage patients effectively. Additionally, it addresses potential issues related to technology use, such as human error and technology failures, and suggests that combining technology with human support can optimize trial outcomes. The guide ultimately aims to provide strategies for overcoming barriers to diversity in clinical trial participation.